News - Page 160 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Small Pharma Reports First Fiscal Quarter 2021 Highlights

Small Pharma Reports First Fiscal Quarter 2021 Highlights

Post published:July 30, 2021
Post category:Press Release

Read more about the article Regulatory Approvals Place Filament Health at the Forefront of Natural Psychedelic Research and Manufacturing

Regulatory Approvals Place Filament Health at the Forefront of Natural Psychedelic Research and Manufacturing

Post published:July 29, 2021
Post category:Press Release

Read more about the article Nova Mentis Files U.S. Patent Application for Psilocybin-Based Therapeutics

Nova Mentis Files U.S. Patent Application for Psilocybin-Based Therapeutics

Post published:July 29, 2021
Post category:Press Release

Read more about the article Levitee Labs Acquires Five Addiction Clinics in Alberta

Levitee Labs Acquires Five Addiction Clinics in Alberta

Post published:July 29, 2021
Post category:Press Release

Read more about the article Levitee Labs Acquires Three Specialized Alberta Pharmacies

Levitee Labs Acquires Three Specialized Alberta Pharmacies

Post published:July 29, 2021
Post category:Press Release

Read more about the article Guy Goodwin joins COMPASS Pathways as Chief Medical Officer

Guy Goodwin joins COMPASS Pathways as Chief Medical Officer

Post published:July 29, 2021
Post category:Press Release

Numinus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into Psychedelic Neurology

Post published:July 29, 2021
Post category:Press Release

Read more about the article Levitee Labs Announces Completion of Acquisition of BlockMD Telemedicine Platform

Levitee Labs Announces Completion of Acquisition of BlockMD Telemedicine Platform

Post published:July 28, 2021
Post category:Press Release

Read more about the article Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Common Shares

Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Common Shares

Post published:July 28, 2021
Post category:Press Release

Read more about the article atai Life Sciences launches InnarisBio to advance delivery of therapeutics for mental health disorders with a licence to develop novel sol-gel intranasal drug delivery platform technology from UniQuest

atai Life Sciences launches InnarisBio to advance delivery of therapeutics for mental health disorders with a licence to develop novel sol-gel intranasal drug delivery platform technology from UniQuest

Post published:July 28, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.